FDA Drug Application (012026) for APRESOLINE-ESIDRIX by NOVARTIS

Back to FDA Applications sponsored by NOVARTIS

Application Number012026
Product Number002
FormTABLET;ORAL
Dosage25MG;15MG
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameAPRESOLINE-ESIDRIX
Active IngredientHYDRALAZINE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE

Active IngredientCount
List of drugs with Active Ingredient HYDRALAZINE HYDROCHLORIDE27
List of drugs with Active Ingredient HYDROCHLOROTHIAZIDE122


Back to FDA Applications sponsored by NOVARTIS